Enable JavaScript to visit this website.

ASPIRE-Hemophilia Award

Awards in Hemophilia Research - United States

The 2017 Investigator Awardees in Hemophilia Research


Valder R. Arruda, MD, PhD
Children’s Hospital of Philadelphia/University of Pennsylvania
Insights into the hemostasis of highly potent Factor IX variants
Nigel S. Key, M.B., Ch.B.
University of North Carolina, Chapel Hill
A Re-evaluation of Fibrinolysis in Hemophilia

The 2016 Investigator Awardees in Hemophilia Research


Stacy E. Croteau, MD
Boston Children’s Hospital
Pharmacokinetic-Tailored Approach to Prophylaxis in Hemophilia A (P-TAP HEMO)
Benjamin G. Keselowsky, PhD
University of Florida
Dual Microparticle System for Induction of Factor VIII Tolerance
Michael B. Nichol, PhD
University of Southern California
Hemophilia Utilization Group Study Part VII (HUGS VII): Costs and Impact of Disease in Older Persons with Hemophilia
Laura J. Sommerville, MS, PhD
Duke University
Understanding the implications of tissue factor loss during wound healing in hemophilia

The 2015 Investigator Awardees in Hemophilia Research


John Sheehan, MD
University of Wisconsin-Madison
The role of extravascular FIX in preventing bleeding complications in hemophilia B

The 2014 Investigator Awardees in Hemophilia Research


David W. Scott, PhD
Uniformed Services University of the Health Sciences
Engineered CARs targeting FVIII-specific B cell
Matthias F. Schneider, PhD
Boston University
Increased circulation time of FVIII by understanding vWF - FVIII interaction under flow. Nano-acoustics tools to study blood clotting
Shannon L. Meeks, MD
Emory University
B-cell epitope mapping in patients with hemophilia A and inhibitors
David Markusic, PhD
University of Florida
Inhibitors, Anaphylaxis, and Gene Therapy: A novel approach to immune tolerance induction 

The 2013 Investigator Awardees in Hemophilia Research


Todd M. Brusko, PhD
University of Florida
Regulatory T Cells with Chimeric Antigen Receptor for Immune Tolerance to Factor VIIIl
Spencer K. Sullivan, MD
University of Pennsylvania Perelman School of Medicine
Children’s Hospital of Philadelphia
Cellular Therapy for the Treatment of Hemophilia A Using Patient-derived Induced Pluripotent Stem Cells Platelet-derived Factor VIII
Xiaomei Wang, MD, PhD
University of Florida Health Sciences Center
Tolerance Induction to Factor IX Using Gene Modified B cells

The 2012 Investigator Awardees in Hemophilia Research

Steven W. Pipe, MD
University of Michigan
Bioengineering Advancements in Recombinant Factor VIII Expression
Shannon L. Carpenter, MD, MS
University of Missouri-Kansas City School of Medicine
Feasibility of high through-put, rapid turnaround mutational analysis for patients with hemophilia using dried blood spots
Denise E. Sabatino, PhD
University of Pennsylvania
Development of Novel Factor VIII Variants for Hemophilia A

The 2011 Investigator Awardees in Hemophilia Research

Leonard A. Valentino, MD
Rush University
Defining the Role of Angiogenesis in Hemophilic Arthropathy
Kathleen Palmer Pratt, PhD
Puget Sound Blood Center
Design Of Less Immunogenic Factor VIII Proteins
Brad E. Hoffman, PhD
University of Florida
TLR-9 Signaling and Immune Tolerance Modulation during Factor IX Gene Therapy
Jordan Adam Shavit, MD, PhD
University of Michigan
Identification of genetic and small molecule modifiers of coagulation disorders using a zebrafish model
Andrea Ferrante, MD
Blood Research Institute, Blood Center of Wisconsin
Prediction Of Inhibitors In Hemophilia A